JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Tănase, Adrian | |
| dc.contributor.author | Cepoida, Petru | |
| dc.contributor.author | Gaibu, Sergiu | |
| dc.contributor.author | Visterniceanu, Dorin | |
| dc.contributor.author | Evdochimov, Larisa | |
| dc.contributor.author | Postolache, Lilia | |
| dc.contributor.author | Cornea, Natalia | |
| dc.date.accessioned | 2020-05-09T16:30:36Z | |
| dc.date.available | 2020-05-09T16:30:36Z | |
| dc.date.issued | 2011 | |
| dc.identifier.citation | TĂNASE, A., CEPOIDA, P., GAIBU, S., et al. Tratamentul cu β-eritropoietina generică (Repretina®) şi calitatea vieţii pacienţilor dializaţi. In: Arta Medica. 2011, nr. 2(45), pp. 266-268. ISSN 1810-1852. | en_US |
| dc.identifier.issn | 1810-1852 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/9286 | |
| dc.description | Centrul Dializă şi Transplant Renal IMSP Spitalul Clinic Republican, Catedra Urologie şi Nefrologie Chirurgicală USMF “N. Testemiţanu”, Al V-lea Congres de Urologie, Dializă şi Transplant Renal din Republica Moldova cu participare internaţională (1-13 iunie 2011) | en_US |
| dc.description.abstract | Summary. The prospective 3-months study of the influence of β-erythropoietine (Repretine®) administration on the quality of life in 20 dialyzed patients is described. Treatment dose was 6,000 UI/week. After the treatment hemoglobin levels increased significantly and 70% patients reported the quality of life amelioration. As the physical component of the quality of life index increased from 33,81±1,56 points (M±m) till 38,51±1,49 points (p<0,05) and the psychological component decreased insignificantly from 45,71±6,97 points till 44,77±6,5 points (p>0,05), than composed health index increased due to the amelioration of the physical stage of the patients, that positively correlated with increased hemoglobin values. | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova | en_US |
| dc.subject.mesh | Renal dialysis | en_US |
| dc.subject.mesh | Quality of life | en_US |
| dc.subject.mesh | Erythropoietin--therapeutic use | en_US |
| dc.subject.mesh | Repretin--therapeutic use | en_US |
| dc.title | Tratamentul cu β-eritropoietina generică (Repretina®) şi calitatea vieţii pacienţilor dializaţi | en_US |
| dc.title.alternative | Generic β-erhythropoietine (Repretine®) therapy and the quality of life of the dialysed population | en_US |
| dc.type | Article | en_US |
Files in this item
This item appears in the following Collection(s)
-
Arta Medica Vol. 45 No.2, 2011 ediţie specială
Materialele celui de-al V-lea Congres de Urologie, Dializă şi Transplant Renal din Republica Moldova cu participare internaţională 1-3 iunie 2011